Group One Trading
GH icon

Group One Trading’s Guardant Health GH Stock Holding History

Group One Trading’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$573K Sell
6,200
-48,300
-89% -$4.85M ﹤0.01% 3219
2025
Q4 		$5.57M Sell
54,500
-15,900
-23% -$1.42M 0.01% 1391
2025
Q3 		$4.4M Sell
70,400
-4,700
-6% -$256K 0.01% 1592
2025
Q2 		$3.91M Buy
75,100
+51,500
+218% +$2.3M 0.01% 1520
2025
Q1 		$1.01M Sell
23,600
-14,300
-38% -$617K ﹤0.01% 2463
2024
Q4 		$1.16M Sell
37,900
-42,800
-53% -$1.2M ﹤0.01% 2437
2024
Q3 		$1.85M Sell
80,700
-52,400
-39% -$1.48M 0.01% 1771
2024
Q2 		$3.84M Sell
133,100
-6,200
-4% -$144K 0.01% 972
2024
Q1 		$2.87M Buy
139,300
+135,000
+3,140% +$2.89M 0.01% 1224
2023
Q4 		$116K Sell
4,300
-18,100
-81% -$475K ﹤0.01% 4331
2023
Q3 		$664K Sell
22,400
-1,300
-5% -$45.7K ﹤0.01% 2638
2023
Q2 		$848K Buy
23,700
+11,000
+87% +$316K ﹤0.01% 2506
2023
Q1 		$298K Sell
12,700
-25,300
-67% -$723K ﹤0.01% 3288
2022
Q4 		$1.03M Sell
38,000
-101,700
-73% -$4.65M ﹤0.01% 2377
2022
Q3 		$7.52M Buy
139,700
+15,400
+12% +$791K 0.01% 898
2022
Q2 		$5.01M Buy
124,300
+89,100
+253% +$4.41M 0.01% 1291
2022
Q1 		$2.33M Sell
35,200
-144,000
-80% -$9.85M ﹤0.01% 2255
2021
Q4 		$17.9M Buy
179,200
+131,300
+274% +$13.6M 0.01% 735
2021
Q3 		$5.99M Sell
47,900
-52,900
-52% -$6.29M 0.01% 1512
2021
Q2 		$12.5M Buy
100,800
+59,600
+145% +$8.02M 0.02% 923
2021
Q1 		$6.29M Sell
41,200
-15,000
-27% -$2.27M 0.01% 1319
2020
Q4 		$7.24M Buy
56,200
+3,200
+6% +$368K 0.01% 1025
2020
Q3 		$5.92M Sell
53,000
-56,900
-52% -$5.21M 0.02% 817
2020
Q2 		$8.92M Buy
109,900
+55,200
+101% +$4.45M 0.04% 500
2020
Q1 		$3.81M Buy
54,700
+400
+0.7% +$30.7K 0.03% 674
2019
Q4 		$4.24M Sell
54,300
-23,300
-30% -$1.68M 0.03% 786
2019
Q3 		$4.95M Sell
77,600
-17,400
-18% -$1.53M 0.04% 573
2019
Q2 		$8.2M Buy
95,000
+53,900
+131% +$4.12M 0.07% 310
2019
Q1 		$3.15M Buy
+41,100
New +$2.28M 0.04% 658

Other funds holding GH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Group One Trading's GH Position: Q3 2025 in Review

Group One Trading sold out of Guardant Health (GH) in Q3 2025, closing a stake of 3,375 shares — an estimated $184K sold.

Group One Trading first reported a position in GH in Q2 2019 and held it in 16 quarters. The position peaked at $13.1M in Q1 2021. 394 funds tracked by Wall St. Rank hold GH as of Q3 2025.

  • Group One Trading reported no remaining Guardant Health position as of Q3 2025 after selling out during the quarter.
  • Group One Trading sold 3,375 Guardant Health shares in Q3 2025, an estimated $184K.
  • Group One Trading first reported a position in Guardant Health in Q2 2019 and held it in 16 quarters.
  • Group One Trading's Guardant Health position peaked at $13.1M in Q1 2021.
  • 394 funds tracked by Wall St. Rank held Guardant Health as of Q3 2025.

Based on Group One Trading's 13F filing for Q3 2025, filed 12 Nov 2025.